Proteus Digital Health, Inc.
11
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
18.2%
2 terminated/withdrawn out of 11 trials
71.4%
-15.1% vs industry average
18%
2 trials in Phase 3/4
80%
4 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
S1916 Digital Medicine Program for Pain Control in Cancer Patients
Role: collaborator
Digital Health Feedback System for Longitudinal Measurement of Medication Adherence During Anti-Retroviral (ARV)Therapy
Role: collaborator
Digital Health Feedback System (DHFS) for Longitudinal Monitoring of ARVs Used in HIV Pre-exposure Prophylaxis (PrEP)
Role: collaborator
Wirelessly Observed Therapy in Comparison to Directly Observed Therapy for the Treatment of Tuberculosis
Role: collaborator
A Digimed Oncology PharmacoTherapy Registry
Role: lead
Digimeds to Optimize Adherence in Patients With Hepatitis C and Increased Risk for Nonadherence
Role: lead
Event Marker Ingested To Trigger Event Recorder 3.0 Psychiatry Study
Role: lead
Helius in Hypertension-I: The UK Hypertension Registry
Role: lead
Reliability, Safety and Usability of the Transplantation Sensor System Combined With Myfortic® in Adult Kidney Transplant Patients
Role: collaborator
Proteus Discover in Subjects With Uncontrolled Hypertension and Type 2 Diabetes
Role: lead
Proteus Sustained Behavior Change Study
Role: lead
All 11 trials loaded